Periodic Reporting for period 1 - BTech (Novel human neurodegenerative disease specific 3D cell-models with applications in drug development and toxicity testing)

The field of neurodegenerative diseases is characterized by low success rates of new drugs that begin human testing and reach the marketplace (8% in comparison to 15% for drugs overall). This is due to the inadequacy of the current in vitro (2D cell culture) and in vivo...